Status:
COMPLETED
Influenza Vaccination and Oral Anticoagulant Therapy
Lead Sponsor:
University Of Perugia
Conditions:
Anticoagulants
Influenza Vaccines
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate INR and INR related index and Warfarin weekly dosage variations after Influenza Vaccination
Detailed Description
The pharmacokinetic and the pharmacodynamic interactions and the possible clinical events connected with the simultaneous administration of Oral Anticoagulants (OA) and the influenza virus vaccine wer...
Eligibility Criteria
Inclusion
- OA Treatment
- Stable anticoagulation (previous two controls in range)
- Presence of indication for Influenza Vaccination
- Life expectancy \> 6 months
- Signed Informed consent
Exclusion
- Absence of stable anticoagulation
- Absence of indication for Influenza Vaccination
- Life expectancy \< 6 months
- Denied Informed Consent
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
End Date :
May 1 2005
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00222638
Start Date
October 1 2004
End Date
May 1 2005
Last Update
September 22 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Perugia
Perugia, Perugia, Italy, 06100